Substrate Artificial Inteligence SA
Substrate Artificial Intelligence SA develops and commercializes advanced medical equipment and technology solutions, primarily serving the healthcare services and equipment sector.
Business. Substrate Artificial Inteligence SA (SAI.MC) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on the development and sale of medical devices. The company is headquartered in Spain and is primarily listed on the BME (Madrid) exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Substrate Artificial Inteligence SA (SAI.MC) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on the development and sale of medical devices. The company is headquartered in Spain and is primarily listed on the BME (Madrid) exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.
Substrate Artificial Intelligence SA has a basic and diluted share count of 111,437,057 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability metrics are not available for direct comparison to industry_config preferred metrics or cohort medians, as the company reported a loss per share of -0.28 EUR in the latest period, with a mean EPS estimate of -0.01 EUR for the upcoming period. This suggests the company is not yet generating positive returns on invested capital or operating margins, which are key metrics for the Advanced Medical Equipment & Technology industry.
The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to assess the risk associated with overreliance on specific markets or customer segments. This lack of transparency could obscure potential vulnerabilities in the business model.
Growth trajectory is uncertain, as no numeric deltas or revenue history are provided in the input data. Analysts have issued one "buy" recommendation and no "strong buy" or "sell" ratings, indicating a cautious but not enthusiastic outlook. The absence of historical revenue data limits the ability to project future performance.
Risk factors include the inability to assess liquidity risk and the lack of disclosed capital structure details. The company has a low dilution potential based on current share counts, but no information is available on potential future dilution from equity offerings or convertible instruments.
Recent events, such as filings or transcripts, are not included in the input data, so no specific developments can be cited to inform the company's current strategic direction or operational performance.
- The company is classified in the Advanced Medical Equipment & Technology industry with high confidence.
- No liquidity risk assessment is available due to missing balance-sheet data.
- The company is currently reporting a loss per share, with no positive returns on invested capital or operating margins.
- Analysts have issued one "buy" recommendation, with no "strong buy" or "sell" ratings.
- Revenue concentration and geographic exposure are not disclosed, limiting visibility into market risks.
- No recent events or filings are available to inform strategic or operational developments.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €17.5M, +103,5% YoY; Operating income +223,1% YoY.
- ▍Revenue €17.5M, +103,5% YoY
- ▍Operating income +223,1% YoY
- ▍Net income +183,4% YoY
- ▍Free cash flow +134,1% YoY
- ▍Net margin 42.1%
Revenue €8.6M, +174,5% YoY; Operating income +51,2% YoY.
- ▍Revenue €8.6M, +174,5% YoY
- ▍Operating income +51,2% YoY
- ▍Net income +41,4% YoY
- ▍Free cash flow +45,2% YoY
- ▍Net margin -102.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,01 |
| Revenue | —no estimate | —no estimate | 19,4M EUR |
| Operating income | —no estimate | —no estimate | -3,0M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Substrate Artificial Inteligence SA Market data — financials · 2026-05-29
- Substrate Artificial Inteligence SA Market data — analyst estimates · 2026-05-29
Ownership & reference
Leadership
- Lorenzo Serratosa GallardoExecutive Chairman of the Board